ULGX Insider Trading Activity and SEC Form 4 Filings
ULGX insider trading summary
No open-market insider purchases or sales of Urologix Inc (ULGX) have been reported on SEC Form 4 in the past 12 months.
Latest ULGX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 20, 2014 | Sidney W Emery Jr | Director | Sell | $854 (10,000 @ $0.09) |
| Nov 19, 2014 | Sidney W Emery Jr | Director | Sell | $854 (10,000 @ $0.09) |
| Aug 26, 2013 | Gregory Fluet | CEO | Buy | $5K (17,500 @ $0.31) |
| Jul 12, 2013 | Mitchell Dann | Director | Buy | $6K (20,000 @ $0.30) |
| Jul 10, 2013 | Gregory Fluet | CEO | Buy | $6K (25,000 @ $0.24) |
| Jul 9, 2013 | Lisa A Ackermann | EVP, Sales & Marketing | Buy | $4K (18,500 @ $0.24) |
| Jul 8, 2013 | Gregory Fluet | CEO | Buy | $6K (30,000 @ $0.20) |
| Jul 5, 2013 | Gregory Fluet | CEO | Buy | $2K (11,200 @ $0.20) |
| Jul 5, 2013 | Gregory Fluet | CEO | Buy | $3K (20,000 @ $0.17) |
| Jul 5, 2013 | Gregory Fluet | CEO | Buy | $1K (5,200 @ $0.21) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.